CTIC · Categories · 8-K
CTIC - SEC Form 8-K filings
CTI BioPharma Corp. (DE) (CTIC) sec form 8-k filings - real-time wire coverage filtered to 8-K only.
Recent 8-K for CTIC
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Events That Accelerate or Increase a Direct Financial Obligation, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Leadership Update8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. (DE) filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- SEC Form 8-K filed by CTI BioPharma Corp.8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- CTI BioPharma Corp. filed SEC Form 8-K: Entry Into A Material Definitive Agreement On March 31, 2021, Cti Biopharma Corp, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits8-K - CTI BIOPHARMA CORP (0000891293) (Filer)
- SEC Form 8-K filed by CTI BioPharma Corp.8-K - CTI BIOPHARMA CORP (0000891293) (Filer)